Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-005120
Filing Date
2025-06-30
Accepted
2025-06-30 17:38:10
Documents
1
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4791
  Complete submission text file 0001562180-25-005120.txt   6260
Mailing Address 21900 BURBANK BOULEVARD 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Gengos Andrew (Reporting) CIK: 0001563623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 251093477

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)